Abstract: O135 serotype Vibrio cholerae isolated from Slovak river was used as a source of surface polysaccharide antigens. Following detoxification procedure, fractions of polysaccharides were separated by size exclusion chromatography. Two resultant fractions were the capsular polysaccharide (Mw ∼ 197,000 Da) and the lipopolysaccharide fragment (Mw ∼ 13,300 Da). These materials were used for preparation of four novel glycoconjugates. Two of them containing detoxified lipopolysaccharide as antigen were prepared by original chemical method using the new biocompatible polymer as carrier of antigen. Additionally, other two conjugates were prepared by direct linking of capsular and detoxified lipopolysaccharide antigens to the protein carrier using adipic acid dihydrazide spacer. The immunogenicities (induced IgM, IgG, IgA antibodies) of all conjugates were determined by enzyme-linked immunosorbent assay. Polymer containing conjugates elicited higher levels of specific anti-lipopolysaccharide IgM and IgG antibodies in comparison with other conjugates without polymer carrier. Enhanced IgM vibriocidal activity of mice antisera was also evident here.
Introduction
Cholera is a severe diarrheal disease caused by the Gram-negative bacterium Vibrio cholerae (Kaper et al. 1995) . Vibrios exist naturally as an inhabitant of surface waters often as a part of zooplankton (Amako et al. 2002) . Transmission to humans is by contaminated water and food (Glass et al. 1991) . Cholera disease symptoms (as a result of production of cholera toxin) are associated with serotypes O1 and non-O1/O139 (Kassis et al. 1985) . The O139 serogroup remains present in India and Bangladesh since last outbreak in 1996 and requires careful monitoring. It has been suggested that the emergence of V. cholerae O139 is the result of a complex chromosomal rearrangement involving the horizontal transfer of genes encoding enzymes involved in O-specific polysaccharide biosynthesis (Comstock et al. 1996; Mukhopadhyay et al. 1998 ). However, choleralike diseases are also caused by other non-O1 serotypes (Janda et al. 1988; Kerketta et al. 2002) . Their genes may be possibly rearranged and they will acquire genes responsible for cholera disease outbreak.
Worldwide prevention of cholera by immunization has not been achieved because of limitation of available vaccines (Provenzano et al. 2006) . Currently available cholera vaccines are based on killed whole cells, or live attenuated cholera causal agents and do not provide long-lasting immunity (Gupta et al. 1992) .
So far, more than 200 serotypes of non-O1 have been reported. Similar to other Gram-negative bacteria, their cell walls contain characteristic lipopolysaccharide (LPS). Moreover, some of them contain capsular polysaccharide (CP) structures as well. Both of these LPS and CP are the main targets of the host immune system. The LPS antigenic structure is composed of lipid A, oligosaccharide core and O-specific polysaccharide (Kjellberg et al. 1997) . The lipid A is linked via the core oligosaccharide to the O-specific polysaccharide and represents an endotoxic principle of the LPS (Chatterjee & Chaudhury 2003) . The lipid A and the core oligosaccharide are conserved parts of the molecule (Holst et al. 1996) . The O-specific polysaccharide is a part of LPS, which contains mono-or oligo-saccharide repeating units with enormous structural variations and determines the serological specificity of the bacterium and its antiserum has a vibriocidal activity. The conjugate consisting of detoxified LPS of Vibrio cholerae, a carrier polysaccharide matrix and immunogenic protein c 2010 Institute of Molecular Biology, Slovak Academy of Sciences has been synthesised. Obtained construct showed reactivity with the antibodies against V. cholerae and can serve as a prospective candidate for preparation of subcellular anti-cholera vaccine (Machová et al. 2002) . The B-cell immunological response to saccharide antigens is generally considered as T-cell independent without immunological memory comprising of only IgM production, without IgM-IgG class-switching. Chemical conjugation of the saccharide moiety to peptide (Alexander et al. 2004) or protein carrier mediates the induction of the T-cell-dependent immune response to saccharide epitopes (Robbins et al. 1995) . Efficient T-celldependent response is manifested by the effective switch of specific IgM isotype antibodies to IgG and IgA, and long-term B cell memory function (Paulovičová et al. 2006) .
The aim of our study was to characterize serological response induced by four different glycoconjugate constructs and to evaluate specific antibody isotypes and their correlations with vibriocidal effectiveness.
Material and methods

V. cholerae O135
Isolate of V. cholerae O135 was obtained from Slovak river Váh near Kolárovo in 2000 and was serotyped in National Reference Center for Vibrionaceae in Komárno, Slovakia. V. cholerae strain non-O1 NRC-66/171; serotype O135; genotype NaG, OmpW
; chemotype a/II (according to Heilberg-Smith-Goodner scheme), which was arbitrarily selected, was used for the glycoconjugates preparations. Serotype O135 represents the most abundant serotype in the collection of V. cholerae strains that were isolated in different aquatic biotypes in Slovakia during 1970-2000.
Bacteria were grown aerobically at 30
• C in medium containing 10 g/L of NaCl and 10 g/L of bacterial pepton (pH 8.6). Upon reaching the late logarithmic growth phase, cultivation was stopped by centrifugation (20 min, 5,000 rpm, 4
• C). Bacteria cells were suspended in distilled water and killed by phenol. The suspension of the killed cells was centrifuged (30 min, 6,000 rpm, 4
• C). V. cholerae biomass was stored at −20
Polysaccharide preparation Cell-wall associated polysaccharides from V. cholerae O135 were obtained by extraction of the wet biomass with 90% phenol in water at 68
• C. The mixture was stirred for 15 min and then cooled to 7
• C in an ice bath. After centrifugation (20 min, 6,000 rpm, 4
• C), three layers were separated (Adams 1972) : (a) the top aqueous layer containing polysaccharide and nucleic acids; (b) the middle phenol layer containing proteins; and (c) the bottom layer containing cell debris and denatured proteins. The upper water phase was siphoned off and dialyzed for 72 h against distilled water. Crude mixture of polysaccharides was recovered by freezedrying.
Analytical methods
Content of protein contaminant in crude polysaccharides was determined spectrophotometrically according to the modified method of Bradford using bovine serum albumin (BSA) (Albumin Fraktion V, Merck, Darmstadt, Germany) as the standard (Sedmak & Grossberg 1977) . Nucleic acid content (RNA contamination) was determined spectrophotometrically at 256 nm. RNA from yeast (Boehringer Mannheim, Germany) was used as the standard. Saccharide content was determined by phenol-sulphuric acid assay using glucose as the standard (Dubois et al. 1956 ).
Detoxification of polysaccharide
Detoxification of polysaccharides was performed by acid hydrolysis (Hisatsune et al. 1985) . Polysaccharides were heated in 30 mL of 1% acetic acid at 105
• C for 3 hours. After the centrifugation (15 min, 12,000 rpm), the detoxified polysaccharides were isolated from supernatant.
Purification of polysaccharide
The detoxified polysaccharides were purified by size exclusion chromatography passing through the column of BioGel P30 (2.5 × 150 cm, mobile phase -distilled water, flow rate 9.5 mL/h). The separation process was monitored using a differential refractometric detector RI-101 (Shodex, Showa Denko K.K., Kawasaki, Japan). Two saccharide fractions were obtained: a CPS and polysaccharide fragment of LPS. As the polysaccharide was detoxified in previous step by mild acid hydrolysis, the fragment of LPS represent detoxified LPS (dLPS). The presence of terminal 3-deoxy-Dmanno-oct-2-ulosonic acid residue in dLPS was determined according to Kondo et al. (1988) .
High-performance liquid chromatography
The molecular weights of two polysaccharide fractions were estimated by the HPLC method. Experiment was performed with a system that included a high-pressure pump (LCP 4020, ECOM s.r.o., Prague, Czech Republic) containing two, in series connected columns (250×8 mm) packed with Biospher GM 300 and GM 1000 sorbent (Labio, a.s., Prague, Czech Republic). The separation process was monitored with a differential refractometric detector RIDK-102 (Laboratorní přístroje, Prague, Czech Republic). As a mobile phase, 0.1 M NaNO3 was used. The flow rate was 0.4 mL/min. A set of pullulans (Polymer Laboratories, Ltd., UK; Varian Inc., USA) was used as the standard for a molecular weight calibration of the system.
Limulus amebocyte lysate (LAL) test
LAL kit (E-TOXATE Kit, Sigma, USA) was used for the detection of endotoxin in samples of CPS and dLPS. LAL is an aqueous extract of blood cells (amebocytes) from the horseshoe crab Limulus polyphemus. Reference standard endotoxin was used as a reference for the assay. If a sample contains less than 0.015 endotoxin units per mL, the sample comprises no endotoxin.
Preparation of conjugates
Two conjugates containing dLPS as antigen: (a) a conjugate based on dLPS densely bound to polymer matrix and BSA (P-BSA-A1); and (b) a conjugate based on dLPS bound to polymer matrix and BSA (P-BSA-A2), were prepared by original chemical method using the new biocompatible materials (polyoxazoline-based polymers) as carriers of antigen according to Farkaš et al. (2010) . Detailed analyses and characterizations of conjugates are available in the original paper. Briefly, poly[2-ethyl-2-oxazoline-co-2-(4-aminophenyl)-2-oxazoline] copolymer was prepared fresh, with molar ratio of 80:20 (ethyloxazoline:aminophenyloxazoline), and degree of polymerization(DP) ≈ 100. Polymer-protein conjugates were prepared by reaction of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride-activated BSA with polymer and quantitatively analyzed by UV spectroscopy. Polymerprotein-antigen conjugates were prepared from dLPS and BSA-polymer by reductive amination; content of dLPS saccharide was determined by colorimetric analysis.
The another two conjugates, containing dLPS and CPS as antigens: (a) a conjugate based on dLPS directly bound to BSA (dLPS-BSA); and (b) a conjugate based on CPS directly bound to BSA (CPS-BSA), were prepared using adipic acid dihydrazide as linker for binding of BSA to polysaccharides according to procedure by Machová et al. (2002) .
Experimental animals and serum collection Seven weeks old female mice BALB/c were used as host animals in all immunization studies. To evaluate the immunogenicity of prepared materials, saline as placebo control, whole cells (WC) and four conjugates mentioned above were applied. Groups each containing 10 mice were injected subcutaneously, without any adjuvant, with 200 µL of the appropriate antigen solution three times in 2-week intervals. 200 µL of conjugates P-BSA-A1 and P-BSA-A2 contained 10 µg of saccharide antigen per dose, whereas 200 µL of dLPS-BSA and CPS-BSA conjugates contained 4 µg of saccharide antigen per dose. The WC were prepared by heating of V. cholerae O135 cells (140
9 cells/mL. Blood samples were collected at the day zero and in 2 weeks after each injection. Pre-immune serum samples were collected as negative controls before immunization. Also one group of non-injected mice was used as an untreated control after immunization. Mice experiments were conducted in compliance with Good Laboratory Practice certificate (Slovak National Accreditation Service), and were practiced in cooperation with Slovak Medical University, Bratislava, Slovakia.
Enzyme-linked immunosorbent assay (ELISA)
The induction of specific anti-dLPS and anti-CPS IgM, IgG and IgA antibodies was determined by ELISA using Immulon 4 HBX microplates (Dynex, Chantilly, USA). Microplates were coated with 100 µL of dLPS or CPS (10 µg/mL) in carbonate buffer (pH 9.6) overnight at 4
• C (Libjaková et al. 2007 ). Microplates were washed with phosphate-buffered saline pH 7.2 three times. Blocking procedure (2 h, room temperature) was accomplished with Milk Diluent/Blocking Solution Concentrate (KPL, USA), diluted 1:20 in distilled water. Serial dilutions of tested sera (pre-immune, WC, conjugates, placebo and untreated control) were added to each well and incubated for 2 h at room temperature. Each mouse serum was tested separately, sera were not pooled. Following washing with phosphate-buffered saline-Tween, the Igs were detected using rat anti-mouse IgM (1:1,500), goat anti-mouse IgG (1:3,000) and goat antimouse IgA (1:3,000) (Beckman Coulter, Fullerton, USA). As a substrate, 100 µL BluePhos Microwell phosphatase substrate system (KPL, USA) was used. Reaction was stopped by addition of 100 µL of 2.5% Na2EDTA.2H2O. The amount of Igs was measured at 630 nm. Calibration curve was constructed using standard Mouse Reference Serum (Bethyl Laboratories Inc., USA). All data were expressed as mean ± SD of 5 mice per group.
Vibriocidal test
The vibriocidal antibody assay, a modification of Quadri method (Quadri et al. 1995) , was carried out with V. cholerae O135 cells. Inoculum was cultivated 16 h at 30
• C in solid medium (1% bacterial peptone, 1% NaCl, 2% agarose, pH 8.6) on Petri's plates. Bacteria were resuspended in a sterile physiological saline to an optical density 0.07 at 590 nm (approximately 10 3 CFU). The assay was performed in sterile non-pyrogenic 96 U-well microplates (Gama, České Budějovice, Czech Republic). 10 µL of bacterial suspension was added to each well with 20 µL guinea pig complement (Sigma, USA) diluted to saline 1:20. Serial diluted mouse sera, pooled from 5 mice after each injection, were added to pre-treated bacterial suspension. Sera ranged from undiluted ones to 1:1,000. Plates were incubated in a shakerincubator at 30
• C for 1 hour. Then, 10 µL of 1% bacterial peptone was added and incubated for 2 hours. End-points of optical densities were measured at 590 nm. Final values were corrected with respect to individual samples (blanks measured in time t = 0 h, 590 nm) and were converted to a percentage of killed bacterial colonies. Lasting vibriocidal activity mediated by IgG was detected by inactivation of IgM by mixing equal volumes of sera with 0.2 M 2-mercaptoethanol (2-ME) and incubating at 4
• C overnight.
Statistical analysis
Statistical comparison between experimental groups was performed using one-way ANOVA and post-hoc Bonferroni's and Tukey's tests. The results were significant if the difference between analysed groups was equal the 95% confidence level (P < 0.05). Statistics were performed with ORI-GIN Pro 8 software (OriginLab Corporation, Northampton, USA).
Results
Isolation of CPS and dLPS
Cell wall polysaccharides obtained from the biomass of V. cholerae O135 consisted of two fractions differing in molecular weights. After detoxification procedure, the larger fraction, the CPS, had Mw ∼ 197,000 Da, whereas the smaller one, dLPS, possessed the Mw ∼ 13,300 Da. Both polysaccharides were rechromatographed on BioGel P30 column and submitted to spectrophotometric analysis. CPS was contaminated with nucleic acids (∼2%) and protein (∼1%); dLPS contained ∼4% of nucleic acid and ∼1.5 % of protein. The purified antigens were conjugated to BSA.
Preparation of conjugates
Four conjugates were prepared (two of them with polymer matrix as vehicle of antigen and another two with antigen directly bound to BSA). The ratio of saccharide/polymer matrix/protein composition and Mw of conjugates are described in Table 1 . Potential endotoxic activity of CPS, dLPS and their conjugates was attested by LAL test that is generally used for the detection and quantification of bacterial endotoxins. The LAL test is an alternative method to the rabbit pyrogen test focussed on detection of pyrogenic substances in sterile parenteral drugs. Our prepared antigens were not pyrogenic (<0.015 endotoxin unit per mL) and were suitable for a subcutaneous application.
The humoral immunity
The immunogenicity of the prepared conjugates was compared with pre-immune sera and anti-WC sera. The Fig. 1 . Induction of specific anti-CPS antibodies (IgM, IgG, IgA) following immunization with CPS-BSA conjugate and WC. Comparisons of all vaccinated groups were done with pre-immune serum. The experimental data are expressed as geometric means ± SEM. Levels of significance: ***, 0.000 < P <0.001; **, 0.001 < P < 0.01, *, 0.01 < P < 0.05. Differences were considered significant where 0.01 < P < 0.05. a Molecular weights of P-BSA-A1 and P-BSA-A2 conjugates were determined by preparative gel permeation chromatography and SDS-PAGE; molecular weights of CPS-BSA and dLPS-BSA conjugates by HPLC method. Conjugate composition: relative average molarity of BSA, polymer matrix, and saccharide antigen in conjugate constructs.
levels of specific IgG, IgM and IgA antibodies against CPS and dLPS were determined 14 days after the 1 st , 2 nd , and 3 rd injection (day 0, 14, 28 and 42) and were carried out in 1:100 antibody titer.
(a) The CPS-BSA conjugate IgM. The level of specific anti-CPS IgM antibodies induced with CPS-BSA conjugate progressively increased during the course of immunization. After the 3 rd injection, CPS-BSA conjugate elicited the statistically significant level of specific IgM (P < 0.001) compared to pre-immune serum (Fig. 1) . The heat-inactivated Fig. 2 . Induction of specific anti-dLPS antibodies (IgM, IgG, IgA) following immunization with P-BSA-A1, P-BSA-A2 and dLPS-BSA conjugates, as well as with WC. Comparisons of all vaccinated groups were done with pre-immune serum. The experimental data are expressed as geometric means ± SEM. Levels of significance: ***, 0.000 < P < 0.001; **, 0.001 < P < 0.01, *, 0.01 < P < 0.05. Differences were considered significant where 0.01 < P < 0.05.
WC induced the increasing amounts of specific anti-CPS IgM during immunization. However, their amounts were slightly lower compared to specific IgM induced by CPS-BSA conjugate. The levels of specific anti-CPS IgM in sera of untreated mice (control) as well in sera of the mice immunized with placebo were practically the same as in pre-immune serum (Fig. 1) .
IgG. Surprisingly, the CPS-BSA conjugate induced insignificant increase of the specific anti-CPS IgG antibodies during immunization of mice. Their amounts were comparable to the values of specific anti-CPS IgG estimated in pre-immune serum. The heat-inactivated WC induced the statistically significant increase of specific anti-CPS IgG after the 3 rd injection (P < 0.001). The levels of specific anti-CPS IgG in sera of untreated mice (control) as well in the sera of the mice immunized with placebo were practically the same as in preimmune serum (Fig. 1) .
IgA. CPS-BSA conjugate elicited statistically significant antibody response after the 3 rd injection (P < 0.05). The heat-inactivated WC did not induce the specific anti-CPS IgA; their values were comparable with pre-immune serum during the whole immunization (Fig. 1) . The experimental data are expressed as geometric means ± SEM. Levels of significance: ***, 0.000 < P < 0.001; **, 0.001 < P < 0.01, *, 0.01 < P < 0.05. Differences were considered significant where 0.01 < P < 0.05.
(b) The dLPS-BSA, P-BSA-A1 and P-BSA-A2 conjugates IgM. The conjugates containing dLPS as antigen elicited important increase of anti-dLPS IgM during immunization (Fig. 2) . The amounts of specific IgM induced by heat-inactivated WC were slightly lower in comparison with all anti-conjugates sera.
IgG. Both conjugates, P-BSA-A1 and P-BSA-A2, already elicited statistically significant antibody response after the first dose (P < 0.01) (Fig. 2) . The anti-dLPS IgG level progressively increased during the immunization with P-BSA-A2 conjugate and achieved the highest level after the 3 rd injection (P < 0.001). Markedly, the P-BSA-A2 conjugate elicited much higher levels of IgG (48 ng/mL) than IgM (33.3 ng/mL). In the case of P-BSA-A1 conjugate, the quantity of specific anti-dLPS IgG after the 3 rd dose decreased, but the value remained statistically significant (P < 0.05). The dLPS-BSA conjugate and heatinactivated WC did not elicit any increase of specific anti-dLPS IgG antibodies. Their amounts were comparable with values of specific anti-dLPS IgG estimated in pre-immune serum.
IgA. P-BSA-A1 and P-BSA-A2 conjugates elicited statistically significant IgA response after the 1 st dose. During the 2 nd and 3 rd doses values of all conjugates remained similar. The heat-inactivated WC induced the low amount of specific anti-dLPS IgA compared with pre-immune serum during the whole immunization (Fig. 2) .
Vibriocidal activity of serum Vibriocidal assay is an important method for the prediction of the protective effect of antigen-induced IgM and IgG antibodies. Vibriocidal activities of all tested samples in undiluted mice sera after the 3 rd injection are presented in Figure 3 . No vibriocidal activity was found in sera after the 1 st and 2 nd injections. The highest levels of vibriocidal antibodies were determined in anti-conjugate sera containing dLPS as antigen, P-BSA-A1 (12.5%) and P-BSA-A2 (14.7%).
Treatment of all tested sera with 2-ME almost eliminated their vibriocidal activities. Destruction of IgM antibodies induced by 2-ME (Fernandez-Miyakawa et al. 2006) indicated that much of vibriocidal activity was mediated by anti-CPS and anti-dLPS IgM isotype. Despite the high levels of specific anti-CPS and antidLPS IgG antibodies determined by ELISA, no vibriocidal activity evoked by IgG was found.
Discussion
Four conjugates containing surface cholera polysaccharides (CPS or dLPS) as antigens were prepared. The first type of conjugates (CPS-BSA and dLPS-BSA) comprised the polysaccharide antigens directly bound to protein (BSA). The other type of conjugates (P-BSA-A1, P-BSA-A2) contained dLPS antigen densely bound to polymer matrix and subsequently to protein.
The difference between P-BSA-A1 and P-BSA-A2 conjugates was in ratio of polysaccharide/polymer bound to one molecule of BSA (Tab. 1). The binding of dLPS to polymer matrix ensured the large amount of the antigen in conjugate since the density of the epitope attachment is crucial for effective activation of the immune system (Paulovičová et al. 2006) .
The levels of specific IgM, IgG and IgA antibodies induced by conjugates as well as the vibriocidal effect of obtained mice anti-sera were compared with data of specific antibodies in pre-immune serum and with anti-WC serum data.
Commonly, the heterogeneity of antigens (inactivated cells, purified components, attenuated strains), different routes of administration (injected, ingested) and the fact they may induce several immune mechanisms, potential vaccines are standardized only for their ability to elicit a protective level of serum antibodies with biological properties that predict their effectiveness (Robbins et al. 1995) .
It is known that the parenterally administered killed whole-cell cholera O1 vaccine or orally administered attenuated cholera O1 strains elicited mainly IgM antibodies (Wasserman et al. 1994 ). Also Kossaczka et al. (2000) showed that vibriocidal activity of sera from patients infected with serotype O139, whose antibodies were specific to its CPS, were mostly mediated by IgM. In contrast, parenterally administered polysaccharide V. cholerae O1-protein conjugate vaccines elicited, in addition to IgM, high levels of anti-polysaccharide IgG (Gupta et al. 1998) .
V. cholerae O135 polymer-protein conjugates, P-BSA-A1 and P-BSA-A2, were applied to mice in amounts of 10 µg of saccharide antigen per dose. Presumably, this amount of antigen was sufficient for induction of high levels of specific anti-dLPS IgG antibodies (Fig. 2.) . The P-BSA-A2 conjugate seems to be more effective and the serial increase of IgG levels during boosting of the antigen may indicate an isotype IgM-IgG switch. However, the serum vibriocidal activity was mediated by IgM only. Destruction of IgM by treatment with 2-ME caused the disappearance of vibriocidal effect. In spite of high levels of specific anti-CPS and anti-dLPS IgG antibodies determined by ELISA, no vibriocidal activity mediated by IgG was found.
The CPS-BSA and dLPS-BSA conjugates contained 4 µg of saccharide antigen per dose. Despite 2.5 µg saccharide antigen/mice per dose recommended on the basis of previous experiments (Chu et al. 1983 ), 4 µg of saccharide per dose was probably insufficient quantity for induction of significant amount of specific IgG antibodies, as well as for vibriocidal activity. The levels of IgM induced by dLPS-BSA were lower than those induced by both polymer containing conjugates. An alternative explanation may be that the conjugates CPS-BSA and dLPS-BSA contained also non-conjugated saccharides. The presence of free saccharide in the immunizing dose may even suppress the development of anti-saccharide IgG producing memory B cells (Peeters et al. 1992) . Grandjean et al. (2009) showed that despite the relatively high amount saccharide per dose (10-20 µg), anti-LPS IgG response on polysaccharide-protein conjugate (V. cholerae O1, Inaba) was lacked because of probable free saccharide contamination in potential vaccine.
However, when these simple conjugates are compared to conjugates containing the same dLPS antigen densely bound to polymer matrix, we noticed remarkable difference. After the 3 rd injection of P-BSA-A1 conjugate, the IgG level unexpectedly decreased. But in comparison with applied WC (3 rd injection) IgG level remains still high (P<0.01). It thus seems that the impact of multiple arrangement of short dLPS to polymer matrix should be considered. As Poszgay et al. (1999) noticed, too high sacharide/protein ratio is not effective. Despite the decrease of IgG after 3 rd P-BSA-A1 injection, polymer-conjugate constructs are evidently better immunogens than the CPS-BSA and dLPS-BSA constructs.
We propose that multiple arrangement of short antigen in the vaccine construct is much more effective to cross B-cell receptors and to evoke production of vibriocidal antibodies.
We could summarize that the P-BSA-A1 and P-BSA-A2 conjugate constructs containing dLPS have induced the highest levels of anti-IgG and anti-dLPS IgM vibriocidal antibodies. The glycoconjugates containing high density of dLPS antigen bound to polymer matrix could be important in creating a new stable, safe and effective immunogenic vaccine playing the key role in protection against the cholera pathogen.
